- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05280951
Focused-PPC: An Integrated Postpartum Care, Education, and Support Model for Women in Ghana (Focused-PPC)
The purpose of this project is to test and evaluate an innovative postpartum care, education, and support model that integrates recommended clinical care, education, and support for women in a group setting.
Aim 1. Develop an innovative integrated group postpartum care, education, and support model entitled Focused-PPC for postpartum women up to one year after delivery.
Aim 2. Implement and evaluate this integrated postpartum care model entitled Focused-PPC in a parallel randomized controlled trial with 192 postpartum women at 4 health centers in Tamale, Ghana.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Principal Investigator
- Telefonnummer: +1 574 631 3224
- E-mail: yadams@nd.edu
Studiesteder
-
-
-
Tamale, Ghana
- Rekruttering
- Bagabaga Health Center
-
Kontakt:
- Project Manager
- Telefonnummer: +233243601588
- E-mail: emefa@savsign.org
-
Tamale, Ghana
- Rekruttering
- Choggu Health Center
-
Kontakt:
- Project Manager
- Telefonnummer: +233243601588
- E-mail: emefa@savsign.org
-
Tamale, Ghana
- Rekruttering
- Kalpohin Health Center
-
Kontakt:
- Project Manager
- Telefonnummer: +233243601588
- E-mail: emefa@savsign.org
-
Tamale, Ghana
- Rekruttering
- Kanvilli Health Center
-
Kontakt:
- Project Manager
- Telefonnummer: +233243601588
- E-mail: emefa@savsign.org
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria at Recruitment:
- 18 years and older, third trimester of pregnancy, able to understand English or "Dagbani" (the local language)
Inclusion Criteria at Enrollment:
- 18 years and older, had a live birth, able to understand English or "Dagbani" (the local language)
Exclusion Criteria:
- Had a stillbirth
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Focused-PPC Group
Focused-PPC will be implemented in 12 groups (3 groups per health center), with each group having 8 postpartum women.
Each group will meet at 1-2 weeks, 6 weeks, and monthly thereafter for up to 1 year postpartum following the Ghana Health Service (GHS) postnatal care schedule.
|
Individual clinical assessments and counseling for each group member will last about 15 minutes.
Then, there will be 1 hour of group time dedicated to education and support.
Each group session will be led by two trained and registered midwives who will provide both clinical care, education, and support as needed.
In addition, each group session will be supported by a project assistant.
Focused-PPC will be implemented in addition to newborn care.
|
|
Aktiv komparator: Standard PNC Group
The control group will contain parallel number of participants as the intervention group in each health center
|
Women in the control group will receive standard postnatal care (PNC) currently practiced in the health centers.
This involves attending PNC visits at the health center within 14 days after birth, at 6 weeks, and monthly thereafter up to one year.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of Post-Birth Warning Signs Identified Per Participant
Tidsramme: 1 year
|
Knowledge of post-birth warning signs will be assessed using a question that asks participants to identify (check all that apply) warning signs of complications. Response options will include nine post-birth warning signs. Each item will be recorded as dichotomous, with a value of 1 assigned if the woman identified the warning sign and 0 if she did not. The total knowledge score will be the sum of these dichotomous items. The mean knowledge score will be calculated as the total knowledge score divided by 9 and reflect the percentage of warning signs known. We will model and test the between treatment and control group's knowledge of post-birth warning signs at each timepoint and between timepoints will be assessed using a repeated measure multivariate analysis of variance (MANOVA) with a time and treatment interaction will be run as the primary analysis controlling for baseline demographic variables. |
1 year
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Postpartum Health Behaviors Practiced
Tidsramme: 1 year
|
Postpartum Health Behaviors will be assessed using a questionnaire.
The questionnaire will identify which PNC visits the participant attended, how participants feed their baby, how often the participant adheres to the 4-star diet, feelings on getting pregnant within 6 months of giving birth, plans on getting pregnant within 6 months of giving birth, and intentions on getting pregnant within 6 months of giving birth.
The researchers expect health behaviors to be different between the Focused-PPC and control groups.
All health behavior questions are all categorical and will be aggregated using latent class analysis.
|
1 year
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
postpartum health status
Tidsramme: 1 year
|
overall health and mental health
|
1 year
|
|
Overall Satisfaction of Focused-PPC Sessions
Tidsramme: 1 year
|
Using a questionnaire, we will record how satisfied participants were with the education received during the Focused-PPC sessions, the clinical care received during the Focused-PPC sessions, whether length of sessions was satisfactory or disliked, whether length of sessions was satisfactory or disliked, whether information provided was satisfactory or disliked, whether peer support was satisfactory or disliked, and whether the group format was liked by participants.
These measures are all categorical and will be aggregated using factor analysis.
|
1 year
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Yenupini J Adams, PhD, BSN, University of Notre Dame
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 21-06-6662
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Efterfødselspleje
-
Xuzhou Medical UniversityIkke rekrutterer endnuIkke-invasiv CAR-T-celleovervågning | BCMA-målrettet PET-skanning | CAR-T-cellebiodistribution og -persistens | GMP-overensstemmende Radiopharmaka-præparation
-
The Affiliated Hospital of Xuzhou Medical UniversityRekrutteringCLL | SLL | CAR-T celleterapiKina
-
Duke UniversityNational Institutes of Health (NIH)RekrutteringHæmatopoietisk stamcelletransplantation | CAR-T celleterapiForenede Stater
-
Patrick C. Johnson, MDRekruttering
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
University Health Network, TorontoIkke rekrutterer endnuLymfom, der modtager CAR-T-terapiCanada
-
The Lymphoma Academic Research OrganisationBristol-Myers Squibb; Novartis; Gilead SciencesRekrutteringHæmatopatologi kvalificeret eller CAR-t-cellebehandlingFrankrig
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Ikke rekrutterer endnuAllogen, CAR-T, proteinsekvestrering, ikke-genredigeretKina
-
Shanghai International Medical CenterUkendtAvanceret solid tumor | PD-1 antistof | CAR-T cellerKina
Kliniske forsøg med Focused-PPC Care
-
Centre Hospitalier Universitaire de NiceAfsluttetHuller i tænderneFrankrig
-
The University of Texas Medical Branch, GalvestonThe University of Texas Health Science Center, HoustonAfsluttetDemens | Flere kroniske tilstandeForenede Stater
-
The University of Texas Health Science Center,...National Institute on Aging (NIA)AfsluttetDemensForenede Stater
-
Children's Hospital of Fudan UniversityRekrutteringSolid tumor | Hæmatologiske maligniteterKina
-
Institute of Hematology & Blood Diseases Hospital...Ikke rekrutterer endnu
-
The Cleveland ClinicYale University; Donaghue Medical Research FoundationAfsluttetFlere kroniske tilstandeForenede Stater
-
Massachusetts General HospitalNational Cancer Institute (NCI); American Cancer Society, Inc.AfsluttetKræft | Brystkræft | Hoved- og halskræft | Skizofreni | Lungekræft | Maniodepressiv | Større depression | GI-kræftForenede Stater
-
Bambino Gesù Hospital and Research InstituteRekruttering
-
Indiana UniversityIkke rekrutterer endnuTraumatisk hjerneskade | TBI | Patienter med traumatisk hjerneskade (TBI).Forenede Stater
-
Dr. Reddy's Laboratories LimitedAfsluttetPsoriasisForenede Stater